Key Takeaways
- • The Canadian Weston family (via holding company Wittington Investments) has agreed to acquire Boots from private equity firm Sycamore Partners for $8.9bn (£6.7bn), marking the UK pharmacy chain's second ownership change in just over a year.
- • The deal ends a 20-year association between Boots and Stefano Pessina, who retains a 44% stake in Boots through his family but is stepping back from operational involvement; Galen Weston Jr will become chair of Boots.
- • Sycamore acquired Boots as part of its $23.7bn purchase of Walgreens Boots Alliance last year and subsequently split the parent company into five standalone entities; the Weston acquisition concludes that restructuring process.
- • Toronto-based Fairfax Financial Holdings, with retail sector investments, partnered with Wittington on the deal, which is expected to close in early 2027.
- • The Westons, who own Canadian grocery chain Loblaws and pharmacy retailer Shoppers Drug Mart, plan to invest in upgrading Boots stores, improving its website, and expanding healthcare services under stable, long-term ownership.
Summary
The Canadian Weston family has secured a definitive agreement to purchase Boots, the UK pharmacy and health-and-beauty retailer, for $8.9bn from Sycamore Partners. The transaction represents a significant strategic entry into the UK market for one of North America's most established retail dynasties and ends speculation about a potential London stock exchange listing for Boots.
Sycamore Partners acquired Boots as part of its acquisition of Walgreens Boots Alliance parent company for $23.7bn in 2024. Following that purchase, Sycamore restructured the group into five independent companies. Stefano Pessina, the executive who has shaped Boots' trajectory for two decades—first merging it with his European pharmaceuticals business Alliance UniChem in 2006, then taking it private with KKR in 2007 before reversing it into Walgreens—will transition out of active management while maintaining a 44% family stake in the business alongside his partner Ornella Barra. Pessina stated he is "delighted to be passing on a thriving Boots to strong and reliable owners who understand the value of its great heritage."
The Weston family's acquisition is backed by Fairfax Financial Holdings, a Toronto-based investment firm with retail sector exposure. Galen Weston Jr, chair of the family's Wittington investment vehicle, will assume the chair role at Boots. The family outlined plans to invest capital in store upgrades, website improvements, and healthcare service expansion under what it characterizes as "stable long-term ownership." The transaction is expected to close in early 2027.
Sycamore Partners acquired Boots as part of its acquisition of Walgreens Boots Alliance parent company for $23.7bn in 2024. Following that purchase, Sycamore restructured the group into five independent companies. Stefano Pessina, the executive who has shaped Boots' trajectory for two decades—first merging it with his European pharmaceuticals business Alliance UniChem in 2006, then taking it private with KKR in 2007 before reversing it into Walgreens—will transition out of active management while maintaining a 44% family stake in the business alongside his partner Ornella Barra. Pessina stated he is "delighted to be passing on a thriving Boots to strong and reliable owners who understand the value of its great heritage."
The Weston family's acquisition is backed by Fairfax Financial Holdings, a Toronto-based investment firm with retail sector exposure. Galen Weston Jr, chair of the family's Wittington investment vehicle, will assume the chair role at Boots. The family outlined plans to invest capital in store upgrades, website improvements, and healthcare service expansion under what it characterizes as "stable long-term ownership." The transaction is expected to close in early 2027.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.